Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP
-
Upload
leo-harris -
Category
Documents
-
view
37 -
download
0
description
Transcript of Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP
Postoperative Radiation for Oral Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: Cavity Squamous Cell Carcinoma:
The EPThe EP
The Difference?The Difference?
Album EP
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Squamous Cell CarcinomaSquamous Cell Carcinoma
• Oral Cavity Cancer is a Surgical Disease
• Use Radiation Postoperatively for Appropriate Patients
• RT can be used as primary therapy for small (T1, T2) tumors of the oral cavity.
• Oral tongue
• Floor of Mouth
• Lip
• Best results are with a combination of external beam radiation and brachytherapy
Difficult getting enough dose to primary with brachytherapy while still delivering adequate dose to the regional nodes IJROBP 1990; 18:1287-92.
Brachytherapy complications: soft tissue necrosis, osteonecrosis
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Squamous Cell CancerSquamous Cell Cancer
• Who needs postop RT?
• Definite Indications:
• 1) Positive Margins
• 2) Multiple Nodes
• 3) Extracapsular Extension
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Squamous Cell CancerSquamous Cell Cancer
• Who needs postop RT?
• Less certain indications:
• 1) Lymphovascular space invasion
• 2) Perineural spread
• 3) Single encapsulated node +• 4) Thick tumors (Tumors 3-9 mm: 44% node+, 7% local
recurrence; >9 mm: 53% subclinical node+, 24% local recurrence Head Neck
2002: 24:513-20)
• 5) Surgeon Vibe
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Squamous Cell CancerSquamous Cell Cancer
• Why give radiation after surgery?
• RTOG 73-03: locally advanced H&N cancers: supraglottic larynx, hypopharynx, oral cavity and oropharynx
• Preop (50 Gy) vs Postop (60 Gy)• Oral Cavity/oropharynx also had definitive RT
arm (65-70 Gy) followed by surgery if residual cancer
• Head Neck Surg 1987;10:19-30
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Squamous Cell CancerSquamous Cell Cancer
• RTOG 73-03 • 277 patients• Ten year follow-up• Improved locoregional control in postoperative
RT arm (65%) vs. preop RT (48%, p=0.04)• Trend toward improved survival: 38% vs 33%,
p=0.10)• Surgical and radiation therapy complications
“similar”. IJROBP 1991;20:21-8.
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Cancer: Radiation DoseCancer: Radiation Dose
• RTOG 7303 established 60 Gy as postop RT dose
• MD Anderson performed prospective randomized trial evaluating RT dose for 240 patients with resected stage III/IV cancers of oral cavity, oropharynx, hypopharynx, larynx
• 180 cGy fractions• Dose ranged from 52.2 Gy to 68.4 Gy• IJROBP 1993; 26:3-11.
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Cancer: Radiation DoseCancer: Radiation Dose
• Patients receiving <54 Gy had significantly higher failure rate.• No dose response beyond 57.6 Gy except for patients with
extracapsular nodal spread.
• +ECE needed at least 63 Gy
• “Clusters” of two or more of the following also predicted increased risk of failure and need for 63 Gy: oral cavity primary, positive/close margins, nerve invasion, >2 positive nodes, largest node >3 cm, treatment delay >6weeks, Zubrod performance status>2
• Moderate to severe complications seen in 7.1%; more if RT dose >63 Gy
• Dose escalation above 63 Gy “does not appear to improve the therapeutic ratio”.
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Cancer: RT + ChemotherapyCancer: RT + Chemotherapy
• Two large randomized trials evaluating RT with or without cisplatin chemotherapy in high-risk resected head and neck squamous cell cancers.
• EORTC• RTOG• NEJM 2004; 350:1945-1952• NEJM 2004: 350:1937-1944
• High risk features: >2 + nodes, +ECE, + margins (EORTC also included perineural spread and vascular tumor embolism)
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Cancer: RT + ChemotherapyCancer: RT + Chemotherapy
• Radiation dose: 60 Gy RTOG; 66 Gy EORTC• Cisplatin 100 mg/m2 days 1, 22, 43 both • 334 EORTC + 459 RTOG patients (793 total)• 26-27% oral cavity primaries
• In combined analysis, only patients with +ECE and/or + margins benefited from addition of cisplatin Head Neck 2005; 27: 843-850
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Cancer: RT + ChemotherapyCancer: RT + Chemotherapy
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Cancer: RT + ChemotherapyCancer: RT + Chemotherapy
Postoperative Radiation for Oral Cavity Postoperative Radiation for Oral Cavity Cancer: RT + ChemotherapyCancer: RT + Chemotherapy
• What’s Next?
• RTOG 0234 evaluated postop chemoRT (cisplatin or docetaxel) + EGFR inhibitor cetuximab (Erbitux)
• This phase II study completed but results are pending
Get to Work!!Get to Work!!
Three-Way Tie for Last